Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy ? ET3 ? for hemophilia A at the Annual Meeting of the American ...

SAN DIEGO -- Results from a small single-center study showed that treatment with a gene therapy involving the use of ...